BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20404029)

  • 1. Induced pluripotent stem cells: what lies beyond the paradigm shift.
    Cox JL; Rizzino A
    Exp Biol Med (Maywood); 2010 Feb; 235(2):148-58. PubMed ID: 20404029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
    Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
    Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Oct4-GFP spermatogonial stem cell line and its application in the reprogramming studies.
    Youn H; Kim SH; Choi KA; Kim S
    J Cell Biochem; 2013 Apr; 114(4):920-8. PubMed ID: 23097321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular coupling of Tsix regulation and pluripotency.
    Navarro P; Oldfield A; Legoupi J; Festuccia N; Dubois A; Attia M; Schoorlemmer J; Rougeulle C; Chambers I; Avner P
    Nature; 2010 Nov; 468(7322):457-60. PubMed ID: 21085182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells.
    Fong YW; Inouye C; Yamaguchi T; Cattoglio C; Grubisic I; Tjian R
    Cell; 2011 Sep; 147(1):120-31. PubMed ID: 21962512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2.
    Pereira CF; Terranova R; Ryan NK; Santos J; Morris KJ; Cui W; Merkenschlager M; Fisher AG
    PLoS Genet; 2008 Sep; 4(9):e1000170. PubMed ID: 18773085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient induction of pluripotent stem cells from granulosa cells by Oct4 and Sox2.
    Mao J; Zhang Q; Ye X; Liu K; Liu L
    Stem Cells Dev; 2014 Apr; 23(7):779-89. PubMed ID: 24083387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct reprogramming of human neural stem cells by OCT4.
    Kim JB; Greber B; Araúzo-Bravo MJ; Meyer J; Park KI; Zaehres H; Schöler HR
    Nature; 2009 Oct; 461(7264):649-3. PubMed ID: 19718018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin 6: a novel surface marker for characterizing mouse pluripotent stem cells.
    Wang L; Xue Y; Shen Y; Li W; Cheng Y; Yan X; Shi W; Wang J; Gong Z; Yang G; Guo C; Zhou Y; Wang X; Zhou Q; Zeng F
    Cell Res; 2012 Jun; 22(6):1082-5. PubMed ID: 22565286
    [No Abstract]   [Full Text] [Related]  

  • 12. Reprogramming of human somatic cells to pluripotency with defined factors.
    Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
    Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tbx3 improves the germ-line competency of induced pluripotent stem cells.
    Han J; Yuan P; Yang H; Zhang J; Soh BS; Li P; Lim SL; Cao S; Tay J; Orlov YL; Lufkin T; Ng HH; Tam WL; Lim B
    Nature; 2010 Feb; 463(7284):1096-100. PubMed ID: 20139965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of pluripotency and reprogramming.
    Na J; Plews J; Li J; Wongtrakoongate P; Tuuri T; Feki A; Andrews PW; Unger C
    Stem Cell Res Ther; 2010 Oct; 1(4):33. PubMed ID: 20974014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional foundation of pluripotency.
    Chambers I; Tomlinson SR
    Development; 2009 Jul; 136(14):2311-22. PubMed ID: 19542351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle and pluripotency: Convergence on octamer‑binding transcription factor 4 (Review).
    She S; Wei Q; Kang B; Wang YJ
    Mol Med Rep; 2017 Nov; 16(5):6459-6466. PubMed ID: 28901500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG.
    Zhao HX; Li Y; Jin HF; Xie L; Liu C; Jiang F; Luo YN; Yin GW; Li Y; Wang J; Li LS; Yao YQ; Wang XH
    Differentiation; 2010; 80(2-3):123-9. PubMed ID: 20510497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of mouse induced pluripotent stem cells without viral vectors.
    Okita K; Nakagawa M; Hyenjong H; Ichisaka T; Yamanaka S
    Science; 2008 Nov; 322(5903):949-53. PubMed ID: 18845712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.